Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma
Status:
RECRUITING
Trial end date:
2029-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare concurrent chemoradiotherapy (CCRT) alone with induction chemotherapy (gemcitabine+cisplatin) plus CCRT in patients with low-risk locoregionally advanced nasopharyngeal carcinoma(NPC).
Phase:
PHASE3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Cancer Hospital of Guizhou Province First Affiliated Hospital of Guangxi Medical University Guangzhou Panyu Central Hospital Hunan Cancer Hospital Tongji Hospital Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Zhongshan People's Hospital, Guangdong, China